Disseminated sporotrichosis and Sporothrix schenckii fungemia as the initial presentation of human immunodeficiency virus infection.
Infection with Sporothrix schenckii causes a localized lymphocutaneous disease in the immunocompetent host, while it frequently results in disseminated disease in the immunocompromised patient. There are a growing number of reports of S. schenckii infection in the human immunodeficiency virus (HIV)-infected population, where the disease usually starts as a localized cutaneous lesion and subsequently disseminates. The optimal treatment of systemic sporotrichosis in HIV-positive patients is as yet unknown. This article presents a case report of disseminated sporotrichosis in an HIV-infected patient, a review of the literature, and discussion of treatment options for HIV-infected patients.
al-Tawfiq
J A
JA
Department of Medicine, Indiana University School of Medicine, Indianapolis 46202, USA.
Wools
K K
KK
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis*; D000935:Antifungal Agents / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D013175:Sporothrix; D013174:Sporotrichosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*
D000935:Antifungal Agents